The small bowel perforation was a critical surgical emergency and the overall morbidity and mortality rates were reported to be 76.5% and 19.1%, respectively[8]. In this study, the overall morbidity and mortality rates were 54.3% and 10.6% respectively, lower than reported in the literature. However, 52.3% (104/199) of patients with small bowel perforation were transferred to ICU after surgery due to critical conditions. For these patients, morbidity and mortality rates were much higher (74.0% and 19.2%).
Data from this study suggest that there is a wide spectrum of etiologies responsible for small bowel perforation. The leading cause was foreign body ingestion and the jujube nucleus (38/54, 70.3%) was the most common kind, which seems to be closely related to Chinese personal eating habits. No perforation secondary to typhoid fever was discovered and only two patients were diagnosed with tuberculosis infection, which are the most common causes in developing countries. According to the medical information database, we found the vast majority of study population were from economically developed areas in eastern China.
There is a gap of etiologies responsible for perforations between non-ICU and ICU groups. Although foreign body ingestion was found to be the most common cause for small bowel perforation, malignant tumor was the leading cause for those in the ICU group and was an independent risk factor for ICU death (P = 0.025). On the one hand, it is related to immune disorder caused by tumor itself; on the other hand, anti-tumor therapy aggravates immunodeficiency when organism confronting with perforation and subsequent infection. According to previous domestic statistics in China, adenocarcinoma (52.9%) and stromal tumor (33.6%) are the most common primary tumors in small bowel[13]. However, there was no case of adenocarcinoma related perforation was found and only 3 cases (3/31) with stromal tumors. Lymphoma was the most common subtype of malignant diseases for small bowel perforation (28/31) in this study. Previous studies reported that perforation was the most common complication in lymphoma cases with a proportion exceeding 25%[14]. Most lymphomas originating from the small bowel are B-cell type, and only 10–25% are T-cell type with a poorer prognosis[15]. On the contrary, T cell lymphoma (17/28,60.7%) was more common than B cell lymphoma (11/28,39.3%) in those patients with perforated small intestinal lymphoma in this study. Furthermore, 35.7% (10/28) of the patients with lymphoma died after surgery, which is similar to the mortality rate (30.4%) of Vaidya’s study.[15].Therefore, it is reasonable to assume that patients with small intestinal lymphoma have a greater risk of perforation with a worse prognosis, especially those with T-cell lymphoma.
In addition, our study demonstrated that the lung was the most common primary site of metastatic tumors causing small bowel perforation. Some researchers suspected that perforations might be related to the target therapies for lung cancer. In this study, three of the five metastatic cases secondary to lung cancer developed perforation just after target therapy, including two with bevacizumab and one with afatinib. These target drugs could inhibit angiogenesis of tumors, subsequently leading to tumor necrosis[16]. They also could regulate the signaling pathways of tumor cells and then cause their apoptosis[17]. These effects would make the lesions prone to perforation. Recently, target therapy has also been reported to cause bowel perforation in metastatic lesions from different primary sites[18].
In this study, the mortality was mainly due to sepsis caused by severe intra-abdominal infections (Fig. 4b), which had been verified in other studies.[9, 19]. Sepsis was thought to be the systemic inflammatory response syndrome (SIRS) of the body against infection which is the so-called sepsis version 1.0. The SIRS criteria include four indicators: body temperature, heart rate, respiratory status, and WBC count. We grouped the WBC count according to the SIRS criteria. However, the result did not show WBC count as a significant factor related to the postoperative mortality in patients with small bowel perforation (Table 3). Clinical practice has shown that the SIRS criteria are too sensitive, and the diagnosis of sepsis 1.0 is highly heterogeneous. Sepsis 3.0 adopted the SOFA score systems to define sepsis by laying emphasis on organ functions and host response to infection[20]. The accuracy of the prognosis of SOFA scores for patients, especially ICU patients, is higher than that of SIRS[21]. APACHE II has been applied in clinical practice earlier than SOFA scoring system, and is currently commonly used for classification and prognostic prediction of critically ill patients. Horiuchi et al. found that APACHE II scores were closely related to the prognosis, and the mortality rate would significantly increase if APACHE II scores were ≥ 20[22]. In this study, the mean APACHE II score of patients in the non-survival group was significantly higher than that of the survival group (19.14 ± 8.62 v.s. 13.48 ± 7.53, P = 0.012) in the patients who entered the ICU after surgery; while there was no significant difference in SOFA score (6.85 ± 4.11 v.s. 4.98 ± 3.43,P = 0.097). Unfortunately, multivariate regression analysis did not indicate that APACHE-II score was independently risk predictor for mortality.
As an excellent indicator reflecting the state of tissue oxygenation and metabolism, blood LAC level has attracted increasing attention. Sepsis 3.0 defines septic shock as requiring vasopressor therapy to maintain mean arterial pressure (MAP) > 65mmHg and blood lactate (LAC) level > 2mmol/L after appropriate fluid replacement[20]. Previous studies have shown that postoperative arterial blood lactate levels are associated with mortality in colorectal perforation patients[23]. In this study, arterial blood LAC level in the survival group was significantly lower than in the non-survival group (2.10 ± 1.26 v.s.3.63 ± 3.33, P = 0.005). Furthermore, lactic acid was analyzed as an independent risk factor of SICU mortality, with cut-off value of ROC 1.920mmol/L(Fig. 4c).
Recent years have witnessed extensive clinical application of serum PCT. Serum PCT level increases with the severity of infection and organ dysfunction[24, 25]. Multiple studies have shown that PCT is a prognostic indicator[26] and PCT-guided therapies may predict treatment response and reduce the length of antibiotic treatments in patients with severe intra-abdominal infection[27, 28]. PCT may be one of the molecules of the central node in sepsis and play an important role in the interaction between cytokine networks and other molecular interactions[29]. Unfortunately, univariate analysis did not suggest a significant correlation between PCT level and mortality in this study. Considering the high missing proportion of 28.8% (30/104) in the ICU group, the clinical application value of serum PCT needs further study.
As the cases and data included in this study are from a single center with a limited sample size, the included population may be different from the overall population in terms of clinical characteristics. Selection and information bias are unavoidable for a retrospective study, which may affect the statistical results. Some important clinical indicators (such as PCT) were incomplete or missing. To provide more reliable and accurate evidence-based medical evidence, prospective multi-center studies are required.